Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Neurodegenerative Diseases Market Share by Type (2020-2026) 1.5.2 NMDA 1.5.3 SSRIs 1.5.4 Dopamine Inhibitors 1.6 Market by Application 1.6.1 Global Neurodegenerative Diseases Market Share by Application (2020-2026) 1.6.2 Parkinson’s Disease 1.6.3 Huntington Disease 1.6.4 Amyotrophic Lateral Sclerosis 1.6.5 Alzheimer’s Disease 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 3 Value Chain of Neurodegenerative Diseases Market 3.1 Value Chain Status 3.2 Neurodegenerative Diseases Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Neurodegenerative Diseases 3.2.3 Labor Cost of Neurodegenerative Diseases 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 4 Players Profiles 4.1 Bayer 4.1.1 Bayer Basic Information 4.1.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.1.3 Bayer Neurodegenerative Diseases Market Performance (2015-2020) 4.1.4 Bayer Business Overview 4.2 Merck 4.2.1 Merck Basic Information 4.2.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.2.3 Merck Neurodegenerative Diseases Market Performance (2015-2020) 4.2.4 Merck Business Overview 4.3 Pfizer 4.3.1 Pfizer Basic Information 4.3.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.3.3 Pfizer Neurodegenerative Diseases Market Performance (2015-2020) 4.3.4 Pfizer Business Overview 4.4 AstraZeneca 4.4.1 AstraZeneca Basic Information 4.4.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.4.3 AstraZeneca Neurodegenerative Diseases Market Performance (2015-2020) 4.4.4 AstraZeneca Business Overview 4.5 Bial 4.5.1 Bial Basic Information 4.5.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.5.3 Bial Neurodegenerative Diseases Market Performance (2015-2020) 4.5.4 Bial Business Overview 4.6 Alector 4.6.1 Alector Basic Information 4.6.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.6.3 Alector Neurodegenerative Diseases Market Performance (2015-2020) 4.6.4 Alector Business Overview 4.7 Addex Pharmaceutical 4.7.1 Addex Pharmaceutical Basic Information 4.7.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.7.3 Addex Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020) 4.7.4 Addex Pharmaceutical Business Overview 4.8 Novartis 4.8.1 Novartis Basic Information 4.8.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.8.3 Novartis Neurodegenerative Diseases Market Performance (2015-2020) 4.8.4 Novartis Business Overview 4.9 Amarin 4.9.1 Amarin Basic Information 4.9.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.9.3 Amarin Neurodegenerative Diseases Market Performance (2015-2020) 4.9.4 Amarin Business Overview 4.10 Yumanity Therapeutics 4.10.1 Yumanity Therapeutics Basic Information 4.10.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.10.3 Yumanity Therapeutics Neurodegenerative Diseases Market Performance (2015-2020) 4.10.4 Yumanity Therapeutics Business Overview 4.11 Biogen Idec 4.11.1 Biogen Idec Basic Information 4.11.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.11.3 Biogen Idec Neurodegenerative Diseases Market Performance (2015-2020) 4.11.4 Biogen Idec Business Overview 4.12 Teva 4.12.1 Teva Basic Information 4.12.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.12.3 Teva Neurodegenerative Diseases Market Performance (2015-2020) 4.12.4 Teva Business Overview 4.13 Boehringer Ingelheim 4.13.1 Boehringer Ingelheim Basic Information 4.13.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.13.3 Boehringer Ingelheim Neurodegenerative Diseases Market Performance (2015-2020) 4.13.4 Boehringer Ingelheim Business Overview 4.14 UCB 4.14.1 UCB Basic Information 4.14.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.14.3 UCB Neurodegenerative Diseases Market Performance (2015-2020) 4.14.4 UCB Business Overview 4.15 Asubio Pharmaceutical 4.15.1 Asubio Pharmaceutical Basic Information 4.15.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.15.3 Asubio Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020) 4.15.4 Asubio Pharmaceutical Business Overview 4.16 Eisai 4.16.1 Eisai Basic Information 4.16.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.16.3 Eisai Neurodegenerative Diseases Market Performance (2015-2020) 4.16.4 Eisai Business Overview 4.17 H.Lundbeck A/S 4.17.1 H.Lundbeck A/S Basic Information 4.17.2 Neurodegenerative Diseases Product Profiles, Application and Specification 4.17.3 H.Lundbeck A/S Neurodegenerative Diseases Market Performance (2015-2020) 4.17.4 H.Lundbeck A/S Business Overview 5 Global Neurodegenerative Diseases Market Analysis by Regions 5.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions 5.1.1 Global Neurodegenerative Diseases Sales by Regions (2015-2020) 5.1.2 Global Neurodegenerative Diseases Revenue by Regions (2015-2020) 5.2 North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 5.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 5.6 South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6 North America Neurodegenerative Diseases Market Analysis by Countries 6.1 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 6.1.1 North America Neurodegenerative Diseases Sales by Countries (2015-2020) 6.1.2 North America Neurodegenerative Diseases Revenue by Countries (2015-2020) 6.2 United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.3 Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.4 Mexico Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7 Europe Neurodegenerative Diseases Market Analysis by Countries 7.1 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 7.1.1 Europe Neurodegenerative Diseases Sales by Countries (2015-2020) 7.1.2 Europe Neurodegenerative Diseases Revenue by Countries (2015-2020) 7.2 Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.3 UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.4 France Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.5 Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.6 Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.7 Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8 Asia-Pacific Neurodegenerative Diseases Market Analysis by Countries 8.1 Asia-Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Neurodegenerative Diseases Revenue by Countries (2015-2020) 8.2 China Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.3 Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.4 South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.5 Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.6 India Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.7 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9 Middle East and Africa Neurodegenerative Diseases Market Analysis by Countries 9.1 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2015-2020) 9.2 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.3 UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.4 Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.5 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.6 South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10 South America Neurodegenerative Diseases Market Analysis by Countries 10.1 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 10.1.1 South America Neurodegenerative Diseases Sales by Countries (2015-2020) 10.1.2 South America Neurodegenerative Diseases Revenue by Countries (2015-2020) 10.2 Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.3 Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.4 Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.5 Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 11 Global Neurodegenerative Diseases Market Segment by Types 11.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Neurodegenerative Diseases Sales and Market Share by Types (2015-2020) 11.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Types (2015-2020) 11.2 NMDA Sales and Price (2015-2020) 11.3 SSRIs Sales and Price (2015-2020) 11.4 Dopamine Inhibitors Sales and Price (2015-2020) 12 Global Neurodegenerative Diseases Market Segment by Applications 12.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Neurodegenerative Diseases Sales and Market Share by Applications (2015-2020) 12.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Applications (2015-2020) 12.2 Parkinson’s Disease Sales, Revenue and Growth Rate (2015-2020) 12.3 Huntington Disease Sales, Revenue and Growth Rate (2015-2020) 12.4 Amyotrophic Lateral Sclerosis Sales, Revenue and Growth Rate (2015-2020) 12.5 Alzheimer’s Disease Sales, Revenue and Growth Rate (2015-2020) 13 Neurodegenerative Diseases Market Forecast by Regions (2020-2026) 13.1 Global Neurodegenerative Diseases Sales, Revenue and Growth Rate (2020-2026) 13.2 Neurodegenerative Diseases Market Forecast by Regions (2020-2026) 13.2.1 North America Neurodegenerative Diseases Market Forecast (2020-2026) 13.2.2 Europe Neurodegenerative Diseases Market Forecast (2020-2026) 13.2.3 Asia-Pacific Neurodegenerative Diseases Market Forecast (2020-2026) 13.2.4 Middle East and Africa Neurodegenerative Diseases Market Forecast (2020-2026) 13.2.5 South America Neurodegenerative Diseases Market Forecast (2020-2026) 13.3 Neurodegenerative Diseases Market Forecast by Types (2020-2026) 13.4 Neurodegenerative Diseases Market Forecast by Applications (2020-2026) 14 Appendix 14.1 Methodology 14.2 Research Data Source

List of Tables and Figures Table Global Neurodegenerative Diseases Market Size Growth Rate by Type (2020-2026) Figure Global Neurodegenerative Diseases Market Share by Type in 2019 & 2026 Figure NMDA Features Figure SSRIs Features Figure Dopamine Inhibitors Features Table Global Neurodegenerative Diseases Market Size Growth by Application (2020-2026) Figure Global Neurodegenerative Diseases Market Share by Application in 2019 & 2026 Figure Parkinson’s Disease Description Figure Huntington Disease Description Figure Amyotrophic Lateral Sclerosis Description Figure Alzheimer’s Disease Description Table SWOT Analysis Figure Porter's Five Forces Analysis Figure Global Neurodegenerative Diseases Market Size and Growth Rate 2015-2026 Table Industry News Table Industry Policies Figure Value Chain Status of Neurodegenerative Diseases Figure Production Process of Neurodegenerative Diseases Figure Manufacturing Cost Structure of Neurodegenerative Diseases Figure Major Company Analysis (by Business Distribution Base, by Product Type) Table Downstream Major Customer Analysis (by Region) Table Bayer Profile Table Bayer Production, Value, Price, Gross Margin 2015-2020 Table Merck Profile Table Merck Production, Value, Price, Gross Margin 2015-2020 Table Pfizer Profile Table Pfizer Production, Value, Price, Gross Margin 2015-2020 Table AstraZeneca Profile Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020 Table Bial Profile Table Bial Production, Value, Price, Gross Margin 2015-2020 Table Alector Profile Table Alector Production, Value, Price, Gross Margin 2015-2020 Table Addex Pharmaceutical Profile Table Addex Pharmaceutical Production, Value, Price, Gross Margin 2015-2020 Table Novartis Profile Table Novartis Production, Value, Price, Gross Margin 2015-2020 Table Amarin Profile Table Amarin Production, Value, Price, Gross Margin 2015-2020 Table Yumanity Therapeutics Profile Table Yumanity Therapeutics Production, Value, Price, Gross Margin 2015-2020 Table Biogen Idec Profile Table Biogen Idec Production, Value, Price, Gross Margin 2015-2020 Table Teva Profile Table Teva Production, Value, Price, Gross Margin 2015-2020 Table Boehringer Ingelheim Profile Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020 Table UCB Profile Table UCB Production, Value, Price, Gross Margin 2015-2020 Table Asubio Pharmaceutical Profile Table Asubio Pharmaceutical Production, Value, Price, Gross Margin 2015-2020 Table Eisai Profile Table Eisai Production, Value, Price, Gross Margin 2015-2020 Table H.Lundbeck A/S Profile Table H.Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020 Figure Global Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Global Neurodegenerative Diseases Revenue ($) and Growth (2015-2020) Table Global Neurodegenerative Diseases Sales by Regions (2015-2020) Table Global Neurodegenerative Diseases Sales Market Share by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue ($) by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue Market Share by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2015 Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2019 Figure North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure North America Neurodegenerative Diseases Revenue ($) and Growth (2015-2020) Table North America Neurodegenerative Diseases Sales by Countries (2015-2020) Table North America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2015 Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2019 Table North America Neurodegenerative Diseases Revenue ($) by Countries (2015-2020) Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2015 Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2019 Figure United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Mexico Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Europe Neurodegenerative Diseases Revenue ($) Growth (2015-2020) Table Europe Neurodegenerative Diseases Sales by Countries (2015-2020) Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2015 Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2019 Table Europe Neurodegenerative Diseases Revenue ($) by Countries (2015-2020) Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2015 Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2019 Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure France Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Asia-Pacific Neurodegenerative Diseases Revenue ($) and Growth (2015-2020) Table Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020) Table Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2015 Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2019 Table Asia-Pacific Neurodegenerative Diseases Revenue ($) by Countries (2015-2020) Table Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2015 Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2019 Figure China Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure India Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Middle East and Africa Neurodegenerative Diseases Revenue ($) and Growth (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Revenue ($) by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2015 Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2019 Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South America Neurodegenerative Diseases Revenue ($) and Growth (2015-2020) Table South America Neurodegenerative Diseases Sales by Countries (2015-2020) Table South America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table South America Neurodegenerative Diseases Revenue ($) by Countries (2015-2020) Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2015 Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2019 Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Table Global Neurodegenerative Diseases Sales by Types (2015-2020) Table Global Neurodegenerative Diseases Sales Share by Types (2015-2020) Table Global Neurodegenerative Diseases Revenue ($) by Types (2015-2020) Table Global Neurodegenerative Diseases Revenue Share by Types (2015-2020) Figure Global NMDA Sales and Growth Rate (2015-2020) Figure Global NMDA Price (2015-2020) Figure Global SSRIs Sales and Growth Rate (2015-2020) Figure Global SSRIs Price (2015-2020) Figure Global Dopamine Inhibitors Sales and Growth Rate (2015-2020) Figure Global Dopamine Inhibitors Price (2015-2020) Table Global Neurodegenerative Diseases Sales by Applications (2015-2020) Table Global Neurodegenerative Diseases Sales Share by Applications (2015-2020) Figure Global Parkinson’s Disease Sales and Growth Rate (2015-2020) Figure Global Parkinson’s Disease Revenue and Growth Rate (2015-2020) Figure Global Huntington Disease Sales and Growth Rate (2015-2020) Figure Global Huntington Disease Revenue and Growth Rate (2015-2020) Figure Global Amyotrophic Lateral Sclerosis Sales and Growth Rate (2015-2020) Figure Global Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020) Figure Global Alzheimer’s Disease Sales and Growth Rate (2015-2020) Figure Global Alzheimer’s Disease Revenue and Growth Rate (2015-2020) Figure Global Neurodegenerative Diseases Sales and Growth Rate (2020-2026) Figure Global Neurodegenerative Diseases Revenue ($) and Growth Rate (2020-2026) Table Global Neurodegenerative Diseases Sales Forecast by Regions (2020-2026) Table Global Neurodegenerative Diseases Revenue Forecast by Regions (2020-2026) Figure North America Neurodegenerative Diseases Sales Forecast (2020-2026) Figure North America Neurodegenerative Diseases Revenue Forecast (2020-2026) Figure Europe Neurodegenerative Diseases Sales Forecast (2020-2026) Figure Europe Neurodegenerative Diseases Revenue Forecast (2020-2026) Figure Asia-Pacific Neurodegenerative Diseases Sales Forecast (2020-2026) Figure Asia-Pacific Neurodegenerative Diseases Revenue Forecast (2020-2026) Figure Middle East and Africa Neurodegenerative Diseases Sales Forecast (2020-2026) Figure Middle East and Africa Neurodegenerative Diseases Revenue Forecast (2020-2026) Figure South America Neurodegenerative Diseases Sales Forecast (2020-2026) Figure South America Neurodegenerative Diseases Revenue Forecast (2020-2026) Table Global Neurodegenerative Diseases Sales Forecast by Types (2020-2026) Table Global Neurodegenerative Diseases Sales Market Share Forecast by Types (2020-2026) Table Global Neurodegenerative Diseases Revenue Forecast by Types (2020-2026) Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Types (2020-2026) Table Global Neurodegenerative Diseases Sales Forecast by Applications (2020-2026) Table Global Neurodegenerative Diseases Sales Market Share Forecast by Applications (2020-2026) Table Global Neurodegenerative Diseases Revenue Forecast by Applications (2020-2026) Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Applications (2020-2026)